Xu Pei

1.5k total citations
29 papers, 992 citations indexed

About

Xu Pei is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xu Pei has authored 29 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Xu Pei's work include Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Xu Pei is often cited by papers focused on Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Xu Pei collaborates with scholars based in China. Xu Pei's co-authors include Bai‐Quan Qiu, Shu‐Qiang Zhu, Xiang Long, Pengfei Zhang, Kun Lin, Feng Lü, Yongbing Wu, Xuemei Zhang, Shiwei Chen and Jianjun Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Molecular Cancer.

In The Last Decade

Xu Pei

25 papers receiving 984 citations

Peers

Xu Pei
Xili Chu China
Li Wu China
Yiqun Yan China
Christopher J. Pelham United States
Jun Zhong China
Xu Pei
Citations per year, relative to Xu Pei Xu Pei (= 1×) peers Huabin Gao

Countries citing papers authored by Xu Pei

Since Specialization
Citations

This map shows the geographic impact of Xu Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Pei more than expected).

Fields of papers citing papers by Xu Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Pei. The network helps show where Xu Pei may publish in the future.

Co-authorship network of co-authors of Xu Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Pei. A scholar is included among the top collaborators of Xu Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Pei. Xu Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Mi, Xu Pei, Shuixiang Deng, et al.. (2025). Optimized Mouse Model of Sepsis‐Associated Encephalopathy: A Rational Standard Based on Modified SHIRPA Score and Neurobehaviors in Mice. CNS Neuroscience & Therapeutics. 31(4). e70365–e70365. 1 indexed citations
3.
Cui, Jialin, Wenjie Liu, Shiyang Zhong, et al.. (2025). Blockade of TIGAR prevents CD8+ T cell dysfunction and elicits anti-AML immunity. Cancer Immunology Immunotherapy. 74(6). 183–183. 1 indexed citations
4.
Pei, Xu, Meng Yu, Chengyu Chen, et al.. (2025). Electrochemical oxidation of aquaculture wastewater by biogas residue biochar: Effects of chloride and removal of organic pollutants. Biomass and Bioenergy. 200. 107959–107959.
5.
Yan, Kun, et al.. (2024). Cooling effects of urban parks under various ecological factors. Urban Climate. 58. 102134–102134. 19 indexed citations
7.
Jiang, Zhiwen, Heng Yang, Wei Ni, et al.. (2024). Attenuation of neuronal ferroptosis in intracerebral hemorrhage by inhibiting HDAC1/2: Microglial heterogenization via the Nrf2/HO1 pathway. CNS Neuroscience & Therapeutics. 30(3). e14646–e14646. 20 indexed citations
9.
Tian, Mi, et al.. (2023). Recent advances in the study of sepsis-induced depression. SHILAP Revista de lepidopterología. 3(3). 239–243. 5 indexed citations
10.
11.
Gao, Jian, Xiang Long, Pengfei Zhang, et al.. (2022). The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis. Molecular Cancer. 21(1). 110–110. 88 indexed citations
12.
Tian, Mi, Shuixiang Deng, Jiaying Li, et al.. (2022). The Key Drivers of Brain Injury by Systemic Inflammatory Responses after Sepsis: Microglia and Neuroinflammation. Molecular Neurobiology. 60(3). 1369–1390. 52 indexed citations
13.
Wang, Yao, Mi Tian, Jiaying Tan, et al.. (2022). Irisin ameliorates neuroinflammation and neuronal apoptosis through integrin αVβ5/AMPK signaling pathway after intracerebral hemorrhage in mice. Journal of Neuroinflammation. 19(1). 82–82. 129 indexed citations
14.
Chen, Jian, Pei Liu, Zheyu Liu, et al.. (2021). A Calcium-Related Immune Signature in Prognosis Prediction of Patients With Glioma. Frontiers in Cell and Developmental Biology. 9. 723103–723103. 4 indexed citations
15.
Chen, Shiwei, Shu‐Qiang Zhu, Xu Pei, et al.. (2021). Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC. Molecular Cancer. 20(1). 144–144. 199 indexed citations
16.
Liu, Jia, et al.. (2020). Circular RNA circ-MAT2B facilitates glycolysis and growth of gastric cancer through regulating the miR-515-5p/HIF-1α axis. Cancer Cell International. 20(1). 171–171. 40 indexed citations
17.
Zhao, Xin, Miaohan Qiu, Xiaozeng Wang, et al.. (2020). Efficacy of clopidogrel and ticagrelor under NT-proBNP in hospitalized ST-elevation acute coronary syndrome patients on percutaneous coronary intervention: CCC-ACS Project Analysis. International Journal of Cardiology. 310. 1–8. 4 indexed citations
18.
Ye, Xudong, Bai‐Quan Qiu, Dian Xiong, et al.. (2020). High level of H3K4 tri-methylation modification predicts poor prognosis in esophageal cancer. Journal of Cancer. 11(11). 3256–3263. 4 indexed citations
19.
Qiu, Bai‐Quan, Pengfei Zhang, Dian Xiong, et al.. (2018). CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non‐small cell lung cancer by regulating Galectin‐1‐AKT/ERK1/2 signaling. Journal of Cellular Physiology. 234(7). 11256–11264. 66 indexed citations
20.
Pei, Xu. (2013). Research progress on individualized treatment of chronic hepatitis C. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026